428 participants
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-20
- Start Date:
- 2024-02-09
- Completion:
- 2026-09-02
Conditions
- Lung Cancer, Non-squamous, Non-small Cell
Interventions
- DRUG
No Results Yet